相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lgr5+ Stem Cells Are Indispensable for Radiation-Induced Intestinal Regeneration
Ciara Metcalfe et al.
CELL STEM CELL (2014)
Lgr5 marks stem/progenitor cells in ovary and tubal epithelia
Annie Ng et al.
NATURE CELL BIOLOGY (2014)
Lymph node-independent liver metastasis in a model of metastatic colorectal cancer
Ida B. Enquist et al.
NATURE COMMUNICATIONS (2014)
In situ validation of an intestinal stem cell signature in colorectal cancer
Jennifer L. Ziskin et al.
GUT (2013)
DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
Dongwei Li et al.
MOLECULAR CANCER THERAPEUTICS (2013)
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Meritxell Huch et al.
NATURE (2013)
Dclk1 distinguishes between tumor and normal stem cells in the intestine
Yuki Nakanishi et al.
NATURE GENETICS (2013)
Maturing antibody-drug conjugate pipeline hits 30
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2013)
The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers
Javier Munoz et al.
EMBO JOURNAL (2012)
Fourth World Antibody-Drug Conjugate Summit
Alain Beck et al.
mAbs (2012)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas
Arnout G. Schepers et al.
SCIENCE (2012)
A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable
Hua Tian et al.
NATURE (2011)
Maytansinoid-Antibody Conjugates Induce Mitotic Arrest by Suppressing Microtubule Dynamic Instability
Emin Oroudjev et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Wnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin
Andrea Haegebarth et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection
Andrew G. Polson et al.
CANCER RESEARCH (2009)
Crypt stem cells as the cells-of-origin of intestinal cancer
Nick Barker et al.
NATURE (2009)
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes
Luigi Quintieri et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Jagath R. Junutula et al.
NATURE BIOTECHNOLOGY (2008)
Identification of stem cells in small intestine and colon by marker gene Lgr5
Nick Barker et al.
NATURE (2007)
A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus
Bernard M. Tijink et al.
CLINICAL CANCER RESEARCH (2006)
APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression
Klaus-Peter Janssen et al.
GASTROENTEROLOGY (2006)
Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo
Owen J. Sansom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors
Terrill McClanahan et al.
CANCER BIOLOGY & THERAPY (2006)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Tissue-specific and inducible Cre-mediated recombination in the gut epithelium
F El Marjou et al.
GENESIS (2004)
Automated selection of DAB-labeled tissue for immunohistochemical quantification
EM Brey et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
分享论文
